Le Lézard
Classified in: Tourism and vacations, Transportation, Covid-19 virus

Aeromexico Reports February 2021 Traffic Results


MEXICO CITY, March 5, 2021 /PRNewswire/ -- Grupo Aeromexico S.A.B. de C.V. ("Aeromexico") (BMV: AEROMEX) today reported February 2021 operational results.

 


 February 


 YTD February 


2021

2020

 Var 


2021

2020

 Var 









 RPKs (itinerary + charter, millions) 








 Domestic 

731

862

-15.2%


1,582

1,791

-11.7%

 International 

561

2,203

-74.6%


1,451

4,834

-70.0%

 Total 

1,292

3,065

-57.9%


3,033

6,625

-54.2%









 ASKs (itinerary + charter, millions) 








 Domestic 

888

1,088

-18.4%


2,042

2,354

-13.3%

 International 

1,164

2,740

-57.5%


2,756

5,909

-53.4%

 Total 

2,052

3,829

-46.4%


4,798

8,263

-41.9%









 Load Factor (itinerary, %) 



p.p.




p.p.

 Domestic 

82.3

79.3

3.1


77.5

76.1

1.4

 International 

52.6

80.4

-27.8


56.3

81.8

-25.5

 Total 

66.1

80.1

-14.0


65.7

80.2

-14.5









 Passengers (itinerary + charter, thousands) 








 Domestic 

743

989

-24.9%


1,597

2,026

-21.2%

 International 

154

501

-69.1%


394

1,113

-64.6%

 Total 

898

1,490

-39.7%


1,990

3,140

-36.6%

Figures may not sum to total due to rounding.
The information included within this report has not been audited and does not provide information on the Company's future performance. Aeromexico's future performance depends on many factors and it cannot be inferred that any period's performance or its year-over-year comparison will be an indicator of similar future performance.

Glossary:

This press release contains certain forward-looking statements that reflect the current views and/or expectations of the Company and its management with respect to its performance, business and future events. We use words such as "believe," "anticipate," "plan," "expect,", "intend," "target," "estimate," "project," "predict," "forecast," "guideline," "should" and other similar expressions to identify forward-looking statements, but they are not the only way we identify such statements. Such statements are subject to a number of risks, uncertainties and assumptions. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in this release. The Company is under no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

About Grupo Aeromexico

Grupo Aeromexico, S.A.B. de C.V. is a holding company whose subsidiaries are engaged in commercial aviation in Mexico and the promotion of passenger loyalty programs. Aeroméxico, Mexico's global airline, has its main operations center in Terminal 2 of the Mexico City International Airport. Its destination network has reach in Mexico, the United States, Canada, Central America, South America, Asia and Europe. The Group's current operating fleet includes  Boeing 787 and 737 aircraft, as well as the latest generation Embraer 190. Aeroméxico is a founding partner of SkyTeam, an alliance that celebrates 20 years and offers connectivity in more than 170 countries, through the 19 partner airlines. Aeroméxico created and implemented a Health and Hygiene Management System (SGSH) to protect its clients and collaborators at all stages of its operation.
www.aeromexico.com 
www.skyteam.co

SOURCE Grupo Aeromexico S.A.B. de C.V.


These press releases may also interest you

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

18 avr 2024
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...



News published on and distributed by: